Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06086145 · ClinicalTrials.gov registry record
Biomarker-estimated Flavanol Intake in Davis (FID)
A clinical trial of Healthy and Diet, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06086145 is a study of Healthy and Diet that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 200 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06086145, a study of Healthy and Diet, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Flavanols are compounds present in plants, including apples, berries, peaches, cocoa-derived products and certain beverages like tea. Following intake, they are absorbed and broken down into smaller compounds called 'metabolites'. Some of these metabolites are excreted in urine. In this study, we hope to collect urine and examine the metabolites to learn more about the types and amounts of flavanols that people are consuming as part of their usual diet.
Interventions
- OTHER No intervention
Study Locations (1)
California
- University of California Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-02 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06086145
The ClinicalTrials.gov registry entry for NCT06086145 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (69% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06086145 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06086145 about?
NCT06086145 is a clinical study titled "Biomarker-estimated Flavanol Intake in Davis (FID)". Flavanols are compounds present in plants, including apples, berries, peaches, cocoa-derived products and certain beverages like tea. Following intake, they are absorbed and broken down into smaller compounds called 'metabolites'. Some of these metabolites are excreted in urine. In this study, we ho...
What is the current status of trial NCT06086145?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-11-02. Estimated completion is 2026-06.
What conditions does trial NCT06086145 study?
This clinical trial studies the following conditions: Healthy, Diet, Adults.
What interventions are being tested in trial NCT06086145?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06086145?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06086145 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.